Showing results (411-420 of 26,310) with videos related to
Sort By:
Pageof 2,631
Bioorganic & Medicinal Chemistry Letters|June 11, 2021
Synthesis and antiproliferative screening of novel doubly modified colchicines containing urea, thiourea and guanidine moietiesJulia Krzywik, Ewa Maj, Anna Nasulewicz-Goldeman, et al.Bioorganic & Medicinal Chemistry Letters|June 11, 2021
Low cytotoxic quinoline-4-carboxylic acids derived from vanillin precursors as potential human dihydroorotate dehydrogenase inhibitorsMilena M Petrović, Cornelia Roschger, Sidrah Chaudary, et al.Bioorganic & Medicinal Chemistry Letters|December 14, 2020
Molecular docking and synthesis of caffeic acid analogous and its anti-inflammatory, analgesic and ulcerogenic studiesFares Hezam Al-Ostoot, Zabiulla, S Grisha, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Synthesis of novel quinoxaline-alkynyl derivatives and their anti-Mycobacterium tuberculosis activityLerato A Raphoko, Karabo Lekgau, Charity M Lebepe, et al.Bioorganic & Medicinal Chemistry Letters|January 10, 2021
Design and synthesis of an anthranyl bridged optically active dinuclear iron(II)-ligand and evaluation of DNA-cleaving activityYoshimi Ichimaru, Koichi Kato, Yoshinori Okuno, et al.Bioorganic & Medicinal Chemistry Letters|May 31, 2021
Effects of N-terminus modified Hx-amides on DNA binding affinity, sequence specificity, cellular uptake, and gene expressionKonstantinos Kiakos, Vijay Satam, Pravin C Patil, et al.Bioorganic & Medicinal Chemistry Letters|June 2, 2021
Chichibabin/isoChichibabin pyridinium synthesis of ma'edamines C and DMika Hirose, Nao Tanaka, Toyonobu UsukiBioorganic & Medicinal Chemistry Letters|May 28, 2021
Discovery of JMJD7 inhibitors with the aid of virtual screening and bioactivity evaluationWenqing Zhang, Kan Li, Tianqi Wang, et al.Bioorganic & Medicinal Chemistry Letters|May 28, 2021
Structure-activity relationships of pyrimidine nucleotides containing a 5'-α,β-methylene diphosphonate at the P2Y6 receptorPaola Oliva, Mirko Scortichini, Clemens Dobelmann, et al.Bioorganic & Medicinal Chemistry Letters|December 22, 2022
Recent advances toward the development of Hsp90 C-terminal inhibitorsEva Amatya, Brian S J BlaggPageof 2,631